Gene · 7874
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunization with a heat-killed prm1 deletion strain protects the host from Cryptococcus neoformans infection. | Emerg Microbes Infect | 2023 | 37526401 | PubTator, text mining | PubMed |
| Emerging roles of Aurora-A kinase in cancer therapy resistance. | Acta Pharm Sin B | 2023 | 37521867 | PubTator, text mining | PubMed |
| Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes. | Acta Pharm Sin B | 2023 | 37521861 | PubTator, text mining | PubMed |
| A Proteomic Survey of the Cystic Fibrosis Transmembrane Conductance Regulator Surfaceome. | Int J Mol Sci | 2023 | 37511222 | PubTator, text mining | PubMed |
| Entire Expressed Peripheral Blood Transcriptome in Pediatric Severe Malarial Anemia. | Res Sq | 2023 | 37503086 | PubTator, text mining | PubMed |
| E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies. | Front Immunol | 2023 | 37497216 | PubTator, text mining | PubMed |
| Increased degradation of FMRP contributes to neuronal hyperexcitability in tuberous sclerosis complex. | Cell Rep | 2023 | 37494191 | PubTator, text mining | PubMed |
| Lysosome-dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer. | Mol Oncol | 2023 | 37491794 | PubTator, text mining | PubMed |
| Deubiquitinase USP16 induces gouty arthritis via Drp1-dependent mitochondrial fission and NLRP3 inflammasome activation. | Arthritis Res Ther | 2023 | 37488647 | PubTator, text mining | PubMed |
| Retraction Note: Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7. | Oncogene | 2023 | 37488195 | PubTator, text mining | PubMed |
| Circular RNAs in hepatocellular carcinoma: biogenesis, function, and pathology. | Front Genet | 2023 | 37485335 | PubTator, text mining | PubMed |
| A novel tumor 4-driver gene signature for the prognosis of hepatocellular carcinoma. | Heliyon | 2023 | 37484410 | PubTator, text mining | PubMed |
| Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4. | bioRxiv | 2023 | 37461630 | PubTator, text mining | PubMed |
| Innovation and Translation of Biological and Biomaterial Treatment for Challenging Musculoskeletal Disorders. | J Orthop Translat | 2023 | 37457312 | PubTator, text mining | PubMed |
| miR-221/222 induce instability of p53 By downregulating deubiquitinase YOD1 in acute myeloid leukemia. | Cell Death Discov | 2023 | 37454155 | PubTator, text mining | PubMed |
| UBA80 and UBA52 fine-tune RNF168-dependent histone ubiquitination and DNA repair. | J Biol Chem | 2023 | 37451480 | PubTator, text mining | PubMed |
| circRPS19 affects HK2‑mediated aerobic glycolysis and cell viability via the miR‑125a‑5p/USP7 pathway in gastric cancer. | Int J Oncol | 2023 | 37449524 | PubTator, text mining | PubMed |
| Exploring the Therapeutic Potential of trans-Chalcone: Modulation of MicroRNAs Linked to Breast Cancer Progression in MCF-7 Cells. | Int J Mol Sci | 2023 | 37445965 | PubTator, text mining | PubMed |
| Diagnostic, Prognostic, and Therapeutic Role for Angiogenesis Markers in Head and Neck Squamous Cell Carcinoma: A Narrative Review. | Int J Mol Sci | 2023 | 37445908 | PubTator, text mining | PubMed |
| Molecular basis for ubiquitin/Fubi cross-reactivity in USP16 and USP36. | Nat Chem Biol | 2023 | 37443395 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7874/papers?page=30